Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Park Avenue Compounding
483
•Park Avenue Compounding•February 8, 2024

Park Avenue Compounding – FDA 483, Feb 8, 2024

Record Details

This FDA Form 483 details ten observations from an inspection of an outsourcing facility.

**Facility and Operations:** The facility compounds various drug products, including Morphine Sulfate, Fentanyl, Ropivacaine, and penicillin/beta-lactam products.

**Violations and Observations:**

1. **Production and Process Controls:** Failure to establish written procedures for production and process controls. Two potency failures for Morphine Sulfate 50 mg in 50 mL of NS (1 mg/mL) were observed (206.5% and 76.0%). Interim CAPA was ineffective, and new batch steps were undocumented. Process validation for Morphine Sulfate was not performed. 2. **Aseptic Processing Area Monitoring:** Deficient environmental monitoring. Active viable monitoring is only performed after production, with questionable device placement. Non-Viable Particle (NVP) monitoring locations are inconsistent. Settle plate placement was observed to be directly behind a spray bottle, potentially inhibiting microbial growth. Surface sampling is limited to one area. Production technician monitoring lacks scientific justification for frequency and acceptance limits, with some samples held to ISO 7 standards instead of ISO 5. 3. **Penicillin Processing:** Operations for penicillin and beta-lactam products were performed in the same hood used for other drug products, with numerous instances documented in 2022 and 2023. 4. **Expiration Dating:** Stability

Company
Park Avenue Compounding
Inspection date
February 8, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Lisa L. Flores (Consumer Safety Officer/ Federal Investigator)
  • Robert J. Ham (Investigator?)
View Company Profile

ID · 989b7159-5889-459d-bc4f-040c205faf6a

Other documents for Park Avenue Compounding
  • 483 - 2025-09-11September 11, 2025
  • 483 - 2021-09-28September 28, 2021
  • 483 - 2019-08-28August 28, 2019
  • 483 - 2017-11-16November 16, 2017
  • WARNING_LETTER - 2014-08-14August 14, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Park Avenue Compounding
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.